Norge -
norsk -
Statens legemiddelverk
pevaryl 1 %
karo pharma ab (1) - ekonazolnitrat - pudder - 1 %
Norge -
norsk -
Statens legemiddelverk
diclofenac diethylamine teva 23.2 mg/ g
teva b.v. - diklofenakdietylamin - gel - 23.2 mg/ g
Den europeiske union -
norsk -
EMA (European Medicines Agency)
exalief
bial - portela ca, s.a. - eslikarbazepinacetat - epilepsi - antiepileptics, - exalief er angitt som tilleggsbehandling behandling hos voksne med delvis-utbruddet anfall med eller uten sekundær generalisering.
Den europeiske union -
norsk -
EMA (European Medicines Agency)
masivet
ab science s.a. - masitinib mesilate - antineoplastiske midler - hunder - behandling av ikke-resectable hund mastcelletumorer (grad 2 eller 3) med bekreftet mutert c-kit tyrosin-kinase reseptor.
Norge -
norsk -
Statens legemiddelverk
duraphat 22.6 mg/ ml
colgate palmolive as - natriumfluorid - dentalvæske, suspensjon - 22.6 mg/ ml
Norge -
norsk -
Statens legemiddelverk
strefen 8.75 mg
reckitt benckiser healthcare (scandinavia) a/s (1) - flurbiprofen - sugetablett med honning/sitronsmak - 8.75 mg
Den europeiske union -
norsk -
EMA (European Medicines Agency)
spikevax (previously covid-19 vaccine moderna)
moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vaksiner - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.
Norge -
norsk -
Statens legemiddelverk
strefen 8.75 mg/ dose
reckitt benckiser healthcare (nordics) a/s - flurbiprofen - munnspray, oppløsning med honning/sitronsmak - 8.75 mg/ dose